NOS3 and type 2 diabetes mellitus: Lin LY found that, in patients with hypercholesterolemia and type 2 diabetes, after were treated by lipid-lowering drug, the counts of CEPCs, the expression and phosphorylation of eNOS in these cells were all increased, moreover, the plasma level of VEGF in these patients was also up-regulated [23].